Merck’s COVID-19 Pill May Be Less Effective Than First Hoped
Nov. 29, 2021 — Merck’s antiviral pill for COVID-19, molnupiravir, appears to be far less effective than early results from the clinical trial first suggested. According to an analysis by scientists at the FDA, the experimental pill cut the risk of hospitalization or death from COVID-19 by about 30%, compared to a placebo, and the … Read more